Associate Director, MSAT, Downstream Drug Substance

Associate Director, MSAT - Downstream

The Associate Director, MSAT - Downstream provides specialized technical leadership and oversight for all downstream manufacturing processes for the company's biologics portfolio executed at CDMOs. This role is responsible for ensuring the robustness, scalability, and compliance of downstream operations through effective technology transfer, validation support, process monitoring, troubleshooting, and lifecycle management activities conducted by external partners.

Key Responsibilities :

• Serve as the primary technical subject matter expert (SME) for downstream processing (chromatography, TFF / UFDF, viral clearance / filtration, etc.).
• Lead and manage the technical aspects of downstream process technology transfers to CDMOs, including documentation review, gap analysis, and risk assessment.
• Provide expert technical oversight of downstream manufacturing operations at CDMOs, including review of batch records, deviation investigations, and change controls.
• Lead or significantly contribute to troubleshooting efforts and root cause investigations for downstream process deviations or performance issues at CDMOs.
• Analyze downstream process data (via CPV program, campaign summaries) to monitor performance, identify trends, and propose process improvements.
• Support process characterization and validation activities (PPQ) for downstream processes executed at CDMOs.
• Evaluate and manage the implementation of downstream process changes and improvements post-approval.
• Author and / or review technical reports, protocols, risk assessments, and relevant sections of regulatory submissions (IND, BLA, MAA, etc.) related to downstream processing.
• Collaborate closely with Upstream MSAT, Validation MSAT, QA, Regulatory, Process Development, Analytical Development, and CDMO technical teams.
• Stay current with advancements in downstream processing technologies, analytics, and regulatory expectations.

Qualifications :

Travel Requirements : Approximately 15-25% travel required (domestic and potentially international) to CDMO sites

Competencies :

Come discover more about Otsuka and our benefit offerings.